These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2697595)

  • 41. The establishment of an interleukin-6-dependent myeloma cell line (FLAM-76) carrying t(11;14)(q13;q32) chromosome abnormality from an aggressive nonsecretory plasma cell leukemia.
    Kubonishi I; Seto M; Shimamura T; Enzan H; Miyoshi I
    Cancer; 1992 Sep; 70(6):1528-35. PubMed ID: 1516003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 14q+ marker chromosomes in multiple myeloma and plasma-cell leukaemia.
    Liang W; Rowley JD
    Lancet; 1978 Jan; 1(8055):96. PubMed ID: 74591
    [No Abstract]   [Full Text] [Related]  

  • 43. Dissecting karyotypic patterns in non-hyperdiploid multiple myeloma: an overview on the karyotypic evolution.
    Jimenez-Zepeda VH; Braggio E; Fonseca R
    Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):552-8. PubMed ID: 23856591
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytogenetics in multiple myeloma and plasma cell leukemia: simultaneous cytogenetic and cytologic studies in 51 patients.
    Gutensohn K; Weh HJ; Walter TA; Hossfeld DK
    Ann Hematol; 1992 Aug; 65(2):88-90. PubMed ID: 1511063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytogenetic findings in 200 patients with multiple myeloma.
    Sawyer JR; Waldron JA; Jagannath S; Barlogie B
    Cancer Genet Cytogenet; 1995 Jul; 82(1):41-9. PubMed ID: 7627933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chromosomes and causation of human cancer and leukemia: XXXVI. The 14q+ anomaly in an American Burkitt lymphoma and its value in the definition of lymphoproliferative disorders.
    Kakati S; Barcos M; Sandberg AA
    Med Pediatr Oncol; 1979; 6(2):121-9. PubMed ID: 460044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Karyotypic variability of human myeloma cell lines].
    Turilova VK; Smirnova TD
    Tsitologiia; 2012; 54(8):621-36. PubMed ID: 23074853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ring chromosomes in hypodiploid and hypotetraploid clones from an elderly patient with plasma cell leukemia.
    Yip MY; Sharma P; Mansberg R; Lam-Po-Tang PR
    Cancer Genet Cytogenet; 1990 Jul; 47(1):47-53. PubMed ID: 2357687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Burkitt-type 8;14 translocation in a case of plasma cell leukemia.
    Yamada K; Shionoya S; Amano M; Imamura Y
    Cancer Genet Cytogenet; 1983 May; 9(1):67-70. PubMed ID: 6839308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High incidence of chromosome abnormalities in IgG3 myeloma.
    Van den Berghe H; Vermaelen K; Louwagie A; Criel A; Mecucci C; Vaerman JP
    Cancer Genet Cytogenet; 1984 Apr; 11(4):381-7. PubMed ID: 6704939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new characteristic karyotypic anomaly in lymphoproliferative disorders.
    Van Den Berghe H; Parloir C; David G; Michaux JL; Sokal G
    Cancer; 1979 Jul; 44(1):188-95. PubMed ID: 582293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Establishment of a human plasma cell line in vitro.
    Burk KH; Drewinko B; Turjillo JM; Ahearn MJ
    Cancer Res; 1978 Aug; 38(8):2508-13. PubMed ID: 566614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chromosome aberrations in 35 primary ovarian carcinomas.
    Pejovic T; Heim S; Mandahl N; Baldetorp B; Elmfors B; Flodérus UM; Furgyik S; Helm G; Himmelmann A; Willén H
    Genes Chromosomes Cancer; 1992 Jan; 4(1):58-68. PubMed ID: 1377010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis.
    Dewald GW; Kyle RA; Hicks GA; Greipp PR
    Blood; 1985 Aug; 66(2):380-90. PubMed ID: 3926026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new human plasma cell line, Karpas 620, with translocations involving chromosomes 1, 11 and 14.
    Nacheva E; Fischer PE; Sherrington PD; Labastide W; Lawlor E; Conneally E; Blaney C; Hayhoe FG; Karpas A
    Br J Haematol; 1990 Jan; 74(1):70-6. PubMed ID: 2310698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Letter: Marker-chromosome 14 in multiple myeloma and plasma-cell leukaemia.
    Wurster-Hill DH; McIntyre OR; Cornwell GG; Maurer LH
    Lancet; 1973 Nov; 302(7836):1031. PubMed ID: 4127256
    [No Abstract]   [Full Text] [Related]  

  • 57. Cytogenetic studies on human myeloma cell lines.
    Jernberg H; Zech L; Nilsson K
    Int J Cancer; 1987 Dec; 40(6):811-7. PubMed ID: 3500922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chromosome studies in plasma cell leukemia and multiple myeloma in transformation.
    Jonveaux P; Berger R
    Genes Chromosomes Cancer; 1992 Jun; 4(4):321-5. PubMed ID: 1377939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chromosomal characteristics of malignant lymphoma in northern pike (Esox lucius) from the United States.
    Whang-Peng J; Sonstegard RA; Dawe C
    Cancer Res; 1976 Oct; 36(10):3554-60. PubMed ID: 953983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A specific chromosome breakpoint associated with mouse plasmacytomas.
    Shepard JS; Pettengill OS; Wurster-Hill DH; Sorenson GD
    J Natl Cancer Inst; 1978 Jul; 61(1):255-8. PubMed ID: 276632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.